Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

8.3%

1 terminated/withdrawn out of 12 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

25%

3 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
7(63.6%)
Phase 3
3(27.3%)
Early Phase 1
1(9.1%)
11Total
N/A(7)
Phase 3(3)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)